← Browse by Condition
Medical Condition
refractory solid tumors
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1
NCT06006273 Phase 1
Recruiting
A Phase Ib Trial of Eribulin in Combination With Irinotecan and Temozolamide in Children With Relapsed or Refractory Solid Tumors
Enrollment
48 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT03739827
Recruiting
Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors
Enrollment
10,000 pts
Location
United States
Sponsor
National Cancer Institute (NCI...